Clinical Trial Update: PLA for HCC and Esophageal ca Serum

View source ↗

Summary

Clinical trial update from National Taiwan University Hospital regarding PLA for hepatocellular carcinoma and esophageal cancer serum; the current trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Hepatocellular Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatocellular Carcinoma, Esophageal Cancer | Status: UNKNOWN